Skip to content
Search

Latest Stories

Submit Guest Post

Royal Astronomical Society staff win Arthurs

Royal Astronomical Society staff win Arthurs

TWO leading astronomers of Royal Astronomical Society's (RAS), Dr Sheila Kanani and Aine O'Brien have won the Sir Arthur Clarke Awards popularly known as Arthurs - for their outstanding work in outreach.

Dr Kanani, a outreach and diversity officer at RAS won the Space Achievement Award for Education and Outreach, and was nominated for the award for her continued outreach work in space and astronomy both before and during the pandemic.


While Aine, a diversity officer was the winner of the Space Achievement Student Award, and won a nomination for co-creating the national ExoMars outreach programme ‘Roving with Rosalind’, establishing and leading the RAS’s Early Career Network in 2020 and the Diversity team for the UK students for the Exploration and Development of Space in 2018.

Sheila and Aine have been connected throughout their time in the space industry, meeting at Space School UK at the University of Leicester in 2008. Aine won a scholarship to attend Space Summer School, at which Sheila was her group mentor.

RAS president Professor Emma Bunce said: "Many congratulations to our team members Sheila and Aine on their Sir Arthur Clarke Awards. It is always a great pleasure to see our own team recognised within the space industry, and for such excellent work in outreach and engagement. Well done!"

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less